Phathom Pharmaceuticals investor relations material
Phathom Pharmaceuticals, Inc. (Phathom), a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company develops products based on its polymer-based nanoparticle delivery system that increase the absorption of bioactive molecules and improves their pharmacokinetic profiles. It also provides PhathomSTAR™ Booster Powder, a proprietary powder formulation in a capsule formulation that creates an increase in bioavailability when diluted with water or food. Phathom was incorporated in 2004 and is headquartered in Redwood City, California."